Список литературы

[1] The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk. ACOG Committee Opinion. SGO N 716, Nov 2017.

[2] Cree IA, White VA, Indave BI, Lokuhetty D. Revising the WHO classification: female genital tract tumours. Histopathology. 2020 Jan; 76(1): 151 - 156. doi: 10.1111/his.13977.

[3] Substrate curvature induces fallopian tube epithelial cell invasion via cell-cell tension in a model of ovarian cortical inclusion cysts. Fleszar AJ, Walker A, Kreeger PK, Notbohm J.Integr Biol (Camb). 2019.

[4] The Extracellular Matrix of Ovarian Cortical Inclusion Cysts Modulates Invasion of Fallopian Tube Epithelial Cells. Fleszar AJ et al. 2018.

[5] Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy. Park KJ et al. 2018.

[6] Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis. Banet N, Kurman RJ.Int J Gynecol Pathol. 2015.

[7] Serous ovarian tumors. Diebold J.Pathologe. 2014.

[8] Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989 - 2015. van der Hel OL, Timmermans M, van Altena AM, Kruitwagen RFPM, Slangen BFM, Sonke GS, van de Vijver KK, van der Aa MA.Eur J Cancer. 2019.

[9] Detailed overview on rare malignant ovarian tumors. Aust S et al.Bull Cancer. 2020.

[10] Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects. Boussios S, Moschetta M, Zarkavelis G, Papadaki A, Kefas A, Tatsi K.Crit Rev Oncol Hematol. 2017.

[11] Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis. Gibbs J, Mei S, Economos K, Lee YC, Kanis MJ.Am J Obstet Gynecol. 2019.

[12] Гинекология: учебник/под ред. В.Г. Брусенко, Г.М. Савельевой. М.: ГЭОТАР-Медиа, 2013.

[13] C. Sourial, V. et al. Ovarian inguinal hernia: systematic review up to Feb 2018. Ann R Coll Surg Engl. 2020.

[14] Ovarian Cyst. Mobeen S, Apostol R.2020 Jul 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.

[15] American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Gynecology. Practice Bulletin N 174: Evaluation and Management of Adnexal Masses. Obstet Gynecol. 2016.

[16] Савельева Г.М. и др. Гинекология. Национальное руководство//М.: ГЭОТАР-Медиа. - 2020.

[17] Герфанова Е.В., Ашрафян Л.А., Антонова И.Б., Алешикова О.И., Ивашина С.В. Опухоли женской репродуктивной системы. 2015.

[18] Munro MG, Critchley HOD, Fraser IS., FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions.

[19] Sehemby M et al. Virilising ovarian tumors: a single-center experience. Endocr Connect. 2018 Dec; 7(12): 1362 - 1369.

[20] Guideline No. 404: Initial Investigation and Management of Benign Ovarian Masses. Wolfman W, Thurston J, Yeung G, Glanc P.J Obstet Gynaecol Can. 2020.

[21] Diagnosis of Ovarian Torsion: Is It Time to Forget About Doppler? Grunau GL, Harris A, Buckley J, Todd NJ.J Obstet Gynaecol Can. 2018.

[22] A review of ovary torsion. Huang C, Hong MK, Ding DC.Ci Ji Yi Xue Za Zhi. 2017 Jul-Sep; 29(3): 143 - 147.

[23] Ovarian Torsion. Guile SL, Mathai JK.2020 Nov 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.

[24] Varras M Tsikini A Polyzos D et al. Uterine adnexal torsion: pathologic and gray-scale ultrasonographic findings. Clin Exp Obstet Gynecol. 2004.

[25] Clinical risk factors for ovarian torsion. Asfour V, Varma R, Menon P.J Obstet Gynaecol. 2015; 35(7): 721-5. doi: 10.3109/01443615.2015.1004524. Epub 2015.

[26] Friedrich L., Meyer R., Levin G. Management of adnexal mass: A comparison of five national guidelines//European Journal of Obstetrics & Gynecology and Reproductive Biology. - 2021.

[27] A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index Maria Lycke 1, Kristjansdottir 2, Karin Sundfeldt 2Randomized Controlled Trial Gynecol Oncol. 2018.

[28] Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF). Bourdel N et al., Eur J Obstet Gynecol Reprod Biol. 2021.

[29] Guideline No. 403: Initial Investigation and Management of Adnexal Masses. Salvador S, Scott S, Glanc P, Eiriksson L, Jang JH, Sebastianelli A, Dean E.J Obstet Gynaecol Can. 2020.

[30] Comparison between Serum HE4 and CA125 as Tumor Markers in Premenopausal Women with Benign Pelvic Mass. Huang X, Wang Y, He X, Kang F, Luo L, Su Z, Ye H.Clin Lab. 2019.

[31] Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis. Zhang L, Chen Y, Wang K.Curr Probl Cancer. 2019.

[32] Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G.J Ovarian Res. 2019.

[33] HE4 in the differential diagnosis of ovarian masses. Granato T, Porpora MG, Longo F, Angeloni A, Manganaro L, Anastasi E.Clin Chim Acta. 2015.

[34] Sagi-Dain L, Lavie O, Auslander R, et al. CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature. Int J Biol Markers 2015.

[35] Sagi-Dain L, Lavie O, Auslander R, et al. CEA in evaluation of adnexal mass: retrospective cohort analysis and review of the literature. Int J Biol Markers 2015.

[36] Diagnosis and Management of Adnexal Masses. Biggs WS, Marks ST.Am Fam Physician. 2016.

[37] The Management of Ovarian Cysts in Postmenopausal Women. RCOG Green-top Guideline No. 34, July 2016.

[38] Simple descriptors and simple rules of the International Ovarian Tumor Analysis (IOTA) Group: a prospective study of combined use for the description of adnexal masses. Peces Rama A, et al. Eur J Obstet Gynecol Reprod Biol. 2015.

[39] Andreotti R. F. et al. O-RADS US risk stratification and management system: a consensus guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee //Radiology. - 2020.

[40] Evaluation of adnexal tumours in the International Ovarian Tumor Analysissystem in reference to histopathological results. Nowak A, Soja M, Masternak M, , , Szubert M.Prz Menopauzalny. 2019.

[41] Retrospective analysis of transvaginal ultrasound-guided aspiration of simple ovarian cysts. Kostrzewa M, , , Stachowiak G.Adv Clin Exp Med. 2019.

[42] Thomassin-Naggara I. et al. Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. JAMA Netw Open. 2020.

[43] O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Andreotti RF, Timmerman et al., Glanc P.Radiology. 2020.

[44] Sasaguri K. et al. External validation of ADNEX MR SCORING system: a single-centre retrospective study. Clin. Radiol. 2019.

[45] Sayasneh A Kaijser J Preisler J et al. A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses. Gynecol Oncol. 2013.

[46] Grimes D.A., Jones L.B., Lopez L.M., Schulz K.F. Oral contraceptives for function ovarian cysts//Cochrane Database Syst. Rev. 2014.

[47] Naz T Akhter Z Jamal T Oral contraceptives versus expectant treatment in the management of functional ovarian cysts. J Med Sci. 2011.

[48] В.И. Кулаков, Л.В. Адамян. Эндоскопия в гинекологии: Руководство для врачей. - М.: Медицина, 2000.

[49] Адамян Л.В. Состояние репродуктивной системы у больных доброкачественными опухолями внутренних гениталий и принципы восстановительного лечения: Дис.... д-ра мед. наук//Москва. - 1985. Москва.

[50] Jacobs IJ Menon U Ryan A et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016.

[51] Greenlee RT Kessel B Williams CR et al. Prevalence, incidence, and natural history of simple ovarian cysts among women > 55 years old in a large cancer screening trial. Am J Obstet Gynecol. 2010.

[52] Sharma A Apostolidou S Burnell M et al. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS). 2012.

[53] van Nagell JR Jr Miller RW DeSimone CP et al. Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol. 2011.

[54] Buys SS Partridge E Black A et al.Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011.

[55] Guidelines for the Use of Laparoscopy for during Pregnancy. SAGES May 2017.

[56] Oral E. et al. Concomitant endometriosis in malignant and borderline ovarian tumours//Journal of Obstetrics and Gynaecology. - 2018. - Т. 38. - N. 8. - С. 1104 - 1109.

[57] Мартынов С.А., Хирургическая тактика при лечении беременных с опухолевидными образованиями и опухолями яичников//Дис. д.м.н. 2016.

[58] Приказ Министерства здравоохранения РФ от 20 октября 2020 г. N 1130н "Об утверждении Порядка оказания медицинской помощи по профилю "акушерство и гинекология".